[1]
V. Modi, Z. Patel, V. Movaliya, N. Kanaki, and M. Zaveri, “Comparative Evaluation of Regulatory Registration & Approval Pathways for Semaglutide 14 mg Tablet in Emerging South American Markets: Chile, Peru and Bolivia”, Int J Drug Reg Affairs, vol. 14, no. 3, pp. 33-39, Sep. 2026.